Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	100.00	91.68	0.00
Graham Fair Price	100.00	44.84	0.00
PEG	100.00	1.15	0.00
Price/Book	100.00	16.69	0.00
Price/Cash Flow	100.00	86.82	0.00
Prices/Earnings	100.00	29.78	0.00
Price/Sales	100.00	29.29	0.00
Price/FCF	100.00	86.82	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	100.00	0.33	0.00
Operating Margin	100.00	0.27	0.00
ROA	n.A.	0.09	n.A.
ROE	n.A.	0.14	n.A.
ROIC	n.A.	0.12	n.A.
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	-0.35	0.00	-100.00
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	0.00	0.05	100.00
EPS QOQ	0.00	0.26	100.00
FCF QOQ	0.00	3.33	100.00
Revenue QOQ	0.00	-0.05	-100.00
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	58.30	100.00
Days Sales Outstanding (DSO)	0.00	23.08	100.00
Inventory Turnover	n.A.	1.54	n.A.
Debt/Capitalization	0.32	0.21	-33.74
Quick Ratio	0.57	0.74	29.18
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	0.00	25.25	100.00
Cash	0.00	4.81	100.00
Capex	0.00	-1.27	-100.00
Free Cash Flow	0.00	4.86	100.00
Revenue	0.00	14.39	100.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	1.08	1.36	25.93
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.00	0.46	100.00
Naive Interpretation	Member

06 - Financial Health · Weak

Rating